Verified Nov 2026
Batteries & E-Mobility
·

·
Since 1994
Fosun Pharma, founded in 1994 and based in Shanghai, China, is a pharmaceutical and healthcare group with 10,000–50,000 employees and estimated revenue of $5–10 billion. The company develops medicines, medical devices, diagnostics, and healthcare services across oncology, immunology, and rare diseases, operating in over 90 countries. Recent collaborations include an exclusive global option agreement with AriBio for an Alzheimer's treatment candidate.
Fosun Pharma at a glance
Revenue
$5-10B
Est. band
Employees
10,000-50,000
Founded
1994
Import activity
146
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
146
Named foreign suppliers
5
Top origins
India · Singapore · China

Shared foreign counterparties do not establish that these companies buy from Fosun Pharma.
What this tells a buyer
The company received 146 recorded shipments, with primary sourcing from India (Gland Pharma at 4,855 shipments) and secondary origins in Singapore and China.
Fosun Pharma manufactures vaccines, biologics, cell therapy, and CAR-T treatments, with active research and development in gene editing and artificial intelligence applications in healthcare.
The company operates across automotive, electric vehicles, medical, renewable energy, and industrial equipment sectors, serving markets in the United States, Europe, and India.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
32 years in operation (founded 1994).
146 US import shipments on record.
Overview
Fosun Pharma, founded in 1994 and based in Shanghai, China, is a pharmaceutical and healthcare group with 10,000–50,000 employees and estimated revenue of $5–10 billion. The company develops medicines, medical devices, diagnostics, and healthcare services across oncology, immunology, and rare diseases, operating in over 90 countries. Recent collaborations include an exclusive global option agreement with AriBio for an Alzheimer's treatment candidate.
At a glance
Attribute | Detail |
|---|---|
Founded | 1994 |
Employees | 10,000-50,000 |
Revenue | $5-10B (estimated) |
Primary capability | Batteries & E-Mobility |
What Fosun Pharma makes
Fosun Pharma manufactures vaccines, biologics, cell therapy, and CAR-T treatments, with active research and development in gene editing and artificial intelligence applications in healthcare.
Trade and customs footprint
The company received 146 recorded shipments, with primary sourcing from India (Gland Pharma at 4,855 shipments) and secondary origins in Singapore and China. US customs bill-of-lading records list 146 inbound shipments across 5 foreign suppliers, with top origins including India · Singapore · China.
Latest developments
2026-09-06 — Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion_Press Release_News_Fosun Pharma (fosunpharma.com)
2026-08-25 — Fosun Pharma Announces 2026 Interim Results Globalization Accelerates Value Realization of Innovative Drugs_Press Release_News_Fosun Pharma (fosunpharma.com)
2026-07-03 — AriBio Draws 42.5 Billion Won Equity Investment from Fosun Pharma - Seoul Economic Daily (sedaily.com)
2026-05-13 — Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease (prnewswire.com)
2026-04-28 — Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework_Press Release_News_Fosun Pharma (fosunpharma.com)
2026-03-24 — Fosun Pharma Announces 2025 Annual Results Innovation and Globalization Propel Fosun Pharma’s High-Quality Growth_Press Release_News_Fosun Pharma (fosunpharma.com)
Company details
The company operates across automotive, electric vehicles, medical, renewable energy, and industrial equipment sectors, serving markets in the United States, Europe, and India. Fosun Pharma was founded in 1994, and has an estimated 10,000-50,000 employees. On the LightSource stability read it is rated "Established & active": 32 years in operation (founded 1994). 146 US import shipments on record.
Frequently asked questions
What does Fosun Pharma make?
Fosun Pharma, founded in 1994 and based in Shanghai, China, is a pharmaceutical and healthcare group with 10,000–50,000 employees and estimated revenue of $5–10 billion. The company develops medicines, medical devices, diagnostics, and healthcare services across oncology, immunology, and rare diseases, operating in over 90 countries. Recent collaborations include an exclusive global option agreement with AriBio for an Alzheimer's treatment candidate.
When was Fosun Pharma founded?
Fosun Pharma was founded in 1994.
How big is Fosun Pharma?
Fosun Pharma has an estimated 10,000-50,000 employees, with revenue in the $5-10B range (estimated).
Does Fosun Pharma import from overseas suppliers?
US customs bill-of-lading records show 146 inbound shipments for Fosun Pharma, with top origins including India · Singapore · China.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
